Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the effects of tablet treatment, circadian and combined
circadian and ultradian subcutaneous hydrocortisone infusion on steroid metabolism and tissue
responses to therapy.